InsidersTradesSigma
Total declarations
Company
▲ Purchases (14 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
14
Disclosed sells
0
T+90 hit rate
58%
T+90 mean return
+31.9%
Across 24 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by KAZIMI A J. Insider active across 1 company, notably Cumberland Pharmaceuticals INC. In total, 28 filings have been published. Split: 14 buys · 0 sell. Total volume traded: €684. History available since 17 March 2021. The latest transaction was disclosed on 1 May 2025 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations28 total
8 shares@ US$4.86Common StockSEC:0001628280-25-029849:0
Ideal exit: 26 Jan 2026 (T+270)
8 shares@ US$4.240.0% of flowCommon StockSEC:0001628280-25-024349:0
Ideal exit: 27 Dec 2025 (T+270)
10 shares@ US$5.540.0% of flowCommon StockSEC:0001628280-25-016742:0
Ideal exit: 28 Nov 2025 (T+270)
3,558 shares@ US$5.174.5% of flowCommon StockSEC:0001628280-25-013522:0
70 shares@ US$1.330.0% of flowCommon StockSEC:0001628280-24-052606:0
Ideal exit: 29 Aug 2025 (T+270)
76 shares@ US$1.150.0% of flowCommon StockSEC:0001628280-24-050107:0
Ideal exit: 29 Jul 2025 (T+270)
62 shares@ US$1.270.0% of flowCommon StockSEC:0001628280-24-045329:0
Ideal exit: 28 Jun 2025 (T+270)
50 shares@ US$1.380.0% of flowCommon StockSEC:0001628280-24-042115:0
44 shares@ US$1.470.0% of flowCommon StockSEC:0001214659-24-016051:0
44 shares@ US$1.470.0% of flowCommon StockSEC:0001214659-24-013689:0
25 shares@ US$1.520.0% of flowCommon StockSEC:0001214659-24-011867:0
25,710 shares@ US$1.8111.3% of flowCommon StockSEC:0001214659-24-005217:0
72 shares@ US$1.690.0% of flowCommon StockSEC:0001214659-23-017028:0
55 shares@ US$1.850.0% of flowCommon StockSEC:0001214659-23-016099:0
55 shares@ US$1.890.0% of flowCommon StockSEC:0001214659-23-014540:0
65 shares@ US$1.680.0% of flowCommon StockSEC:0001214659-23-013090:0
65 shares@ US$1.640.0% of flowCommon StockSEC:0001214659-23-012220:0
37,205 shares@ US$1.9217.8% of flowCommon StockSEC:0001209191-23-020349:0
20,000 shares@ US$2.590.058% mcap18.9% of flowCommon StockSEC:0001209191-22-026135:0
18 shares@ US$4.140.0001% mcap0.0% of flowCommon StockSEC:0001209191-22-002457:0
Ideal exit: 28 Aug 2022 (T+270)
15 shares@ US$2.670.0000% mcap0.0% of flowCommon StockSEC:0001209191-21-067888:0
Ideal exit: 29 Jul 2022 (T+270)
15 shares@ US$2.690.0000% mcap0.0% of flowCommon StockSEC:0001209191-21-063222:0
Ideal exit: 28 Jun 2022 (T+270)
15 shares@ US$2.880.0000% mcap0.0% of flowCommon StockSEC:0001209191-21-058517:0
Ideal exit: 29 May 2022 (T+270)
15 shares@ US$3.030.0000% mcap0.0% of flowCommon StockSEC:0001209191-21-055496:0
Ideal exit: 11 Jan 2022 (T+270)
15 shares@ US$2.910.0000% mcap0.0% of flowCommon StockSEC:0001209191-21-055504:0
Ideal exit: 28 Mar 2022 (T+270)
25 of 28 declarations
About KAZIMI A J
Kazimi A J is an executive at Cumberland Pharmaceuticals Inc.
